100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2005 Research Grants

David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer
Cambridge Research Institute

Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer
Georgetown University

Steven D. Leach, M.D.
High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System
Johns Hopkins University 

Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer
Johns Hopkins University 

Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development
Technical University of Munich

Diane Simeone, M.D.
Pancreatic Cancer Stem Cells
University of Michigan 
 
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis
University of Utah

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303